Dr. Mikael Ekström has joined Iconovo as Vice President Development
Mikael has nearly 30 years of experience in inhalation products and has recently come from a role as Senior Director Inhalation Product Development at AstraZeneca, where he previously held leading positions in product development and drug development. He received his PhD in organic chemistry at Lund University in 1989.
Mikael will be responsible for the development of Iconovo’s new products, with special focus on ICOone and inhaled vaccines. He will also be part of Iconovo’s management team. This is an important reinforcement of Iconovo’s organization ahead of the undertaking to developing more own products.
“We are very pleased to have Mikael on our team. His many years of experience and expertise in the field of inhalation will of course be very useful when Iconovo is entering the next exciting phase,” said Iconovo’s CEO, Orest Lastow.